Venker Eric 4
4 · Roivant Sciences Ltd. · Filed Feb 24, 2026
Insider Transaction Report
Form 4
Venker Eric
President & Immunovant CEO
Transactions
- Tax Payment
Common Shares
[F1]2026-02-20$27.15/sh−7,051$191,435→ 1,647,546 total
Footnotes (1)
- [F1]Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Eric Venker|2026-02-24